Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • J.F. Forbes - (Author)
  • I. Sestak - (Author)
  • A. Howell - (Author)
  • B. Bonanni - (Author)
  • N. Bundred - (Author)
  • C. Levy - (Author)
  • G. Von Minckwitz - (Author)
  • W. Eiermann - (Author)
  • P. Neven - (Author)
  • M. Stierer - (Author)
  • C. Holcombe - (Author)
  • R.E. Coleman - (Author)
  • L. Jones - (Author)
  • I. Ellis - (Author)
  • J. Cuzick - (Author)
  • IBIS-II InvestIgators - (Author)
  • K. Kast - , Department of Gynecology and Obstetrics (Author)

Details

Original languageEnglish
Pages (from-to)866-873
Number of pages8
JournalThe Lancet
Publication statusPublished - 2016
Peer-reviewedYes

External IDs

Scopus 84959482139

Keywords

Sustainable Development Goals